# Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)

> **NCT07150195** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 32 (estimated)

## Conditions studied

- Cirrhoses, Liver
- Hepatic Encephalopathy (HE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07150195
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-09
- **Final completion:** 2026-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07150195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07150195, "Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07150195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*